Nicholas Franks
Nicholas Peter Franks FRS FRSB (born 14 October 1949) has been Professor of Biophysics and Anaesthetics at Imperial College London since 1993.[1] His research focuses on how general anaesthetics act at the cell and molecular levels as well as with neuronal networks.[2] Franks holds patents on use of xenon gas as a neuroprotectant [3] and has published research on the use of the anesthetic properties of xenon.[4][1]
He was educated at Mill Hill School and King's College London (BSc 1972; PhD 1975).[5] He was a Lecturer in Biophysics at Imperial College London from 1977 to 1989 and a Reader in Biophysics from 1989 to 1993.
Awards & Honors
Along with being made a Fellow of the Royal Society in 2011, Franks is also a Fellow of the Royal Society of Biology. He has served as a Distinguished Lecturer in Neuroscience at the University of Toronto and as Stuart Cullen Lecture, University of California San Francisco.
References
- ^ "Professor Nick Franks, FRS". Imperial College London. Retrieved 15 March 2016.
- ^ Franks, Nicholas (2014). "The role of K2P channels in anaesthesia and sleep". European Journal of Physiology. 467: 907–916. doi:10.1007/s00424-014-1654-4.
- ^ Dickinson, R (2007). "Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology". Anesthesiology. 107: 756–67. doi:10.1097/01.anes.0000287061.77674.71. PMID 18073551.
- ^ Franks, Nicholas (1998). "How does xenon produce anaesthesia?". Nature. 396: 324. doi:10.1038/24525. PMID 9845069.
- ^ ‘FRANKS, Prof. Nicholas Peter’, Who's Who 2016, A & C Black, an imprint of Bloomsbury Publishing plc, 2016
External links
Neuroprotexeon Scientific Advisory Board: http://neuroprotexeon.com/scientific-advisory-board/
THE LANCET Neurology
Neurologic Critical Care